You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Last Updated: October 1, 2023

Cosette Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for COSETTE, and what generic and branded alternatives to COSETTE drugs are available?

COSETTE has one hundred and sixteen approved drugs.

Summary for Cosette
US Patents:0

Drugs and US Patents for Cosette

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cosette BENICAR HCT hydrochlorothiazide; olmesartan medoxomil TABLET;ORAL 021532-002 Jun 5, 2003 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial
Cosette PROCHLORPERAZINE prochlorperazine SUPPOSITORY;RECTAL 040058-001 Nov 24, 1993 AB RX No Yes ⤷  Try a Trial ⤷  Try a Trial
Cosette CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE betamethasone dipropionate; calcipotriene SUSPENSION;TOPICAL 210765-001 May 11, 2020 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Cosette CAPTOPRIL captopril TABLET;ORAL 074433-002 Feb 13, 1996 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Cosette CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077048-003 Nov 16, 2004 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Cosette PROMETHAZINE HYDROCHLORIDE promethazine hydrochloride SUPPOSITORY;RECTAL 040428-002 Mar 31, 2003 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Cosette

Paragraph IV (Patent) Challenges for COSETTE drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 5 mg/20 mg and 10 mg/40 mg ➤ Subscribe 2008-02-11
➤ Subscribe Tablets 5 mg, 20 mg and 40 mg ➤ Subscribe 2006-04-25
➤ Subscribe Tablets 40 mg/12.5 mg and 40 mg/25 mL ➤ Subscribe 2007-02-15
➤ Subscribe Tablets 625 mg ➤ Subscribe 2009-07-01
➤ Subscribe Capsules 30 mg ➤ Subscribe 2009-02-27
➤ Subscribe Tablets 10 mg/20 mg and 5 mg/40 mg ➤ Subscribe 2008-03-31
➤ Subscribe Tablets 20 mg/12.5 mg ➤ Subscribe 2007-05-11
➤ Subscribe Tablets 5 mg and 10 mg ➤ Subscribe 2013-07-10
➤ Subscribe Powder for Oral Suspension 1.875 g/Packet and 3.75 g/Packet ➤ Subscribe 2010-04-09
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.